Ignite Creation Date:
2024-05-06 @ 4:17 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04933942
Status:
WITHDRAWN
Last Update Posted:
2023-05-24
First Post:
2021-06-14
Brief Title:
Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-14
First Submit QC Date:
June 14 2021
Study First Post Date:
2021-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-23
Last Update Post Date:
2023-05-24
Last Update Post Date Type:
ACTUAL